INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/29/2024
Back to search
Official data from USPTO
DFE PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
01/29/2024
Classification
Registered
Trademark type
Combined
Nice classes
1
Filing date
10/24/2011
Registration date
10/16/2012
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2023
Last transaction
04/28/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
LUDEMAN, JESSICA ANN
Law office
L40
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the wording "DFE PHARMA" in stylized gray characters. To the left is a gray shield with a white emblem consisting of two half circles. The shield is outlined in light orange on the upper left and orange the remainder of the way around. The upper left portion of the shield is shaded in white.
Holders and representatives
Holders
DFE Pharma GmbH & Co. KG
DMV Fonterra Excipients GmbH & Co. KG
Representatives
ROBERTO LEDESMA LAW OFFICE OF ROBERTO LEDESMA
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Excipients for use in the manufacture of pharmaceutical preparations and veterinary preparations; cellulose; lactose to be used in the manufacture of pharmaceutical and veterinary preparations; starch for use in the manufacture of pharmaceutical and veterinary preparations; sodium
Publications
History of USPTO decisions and trademark events.
43 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/08/2024
INPC
INVALIDATION PROCESSED
01/06/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
12/28/2023
C71T
CANCELLED SECTION 71
04/28/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/11/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
10/16/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/22/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/13/2020
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
09/24/2018
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
09/24/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/19/2018
ES75
TEAS SECTION 71 & 15 RECEIVED
09/11/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/11/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/16/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/30/2015
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
06/22/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/04/2013
FIMP
FINAL DISPOSITION PROCESSED
06/04/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/16/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
10/16/2012
GPNX
NOTIFICATION PROCESSED BY IB
09/23/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/31/2012
PUBO
PUBLISHED FOR OPPOSITION
07/31/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/11/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/11/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/11/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/26/2012
ALIE
ASSIGNED TO LIE
06/25/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/31/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/31/2012
RFNT
REFUSAL PROCESSED BY IB
04/27/2012
MAFR
APPLICATION FILING RECEIPT MAILED
04/17/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/12/2012
RFRR
REFUSAL PROCESSED BY MPU
04/12/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/12/2012
CNRT
NON-FINAL ACTION WRITTEN
04/11/2012
DOCK
ASSIGNED TO EXAMINER
04/11/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2012
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/10/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/09/2012
Continuous trademark protection
Get notified about every new filing that threatens DFE PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.